Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
54.50
+2.10 (4.01%)
Feb 17, 2025, 9:00 AM CST
35.57%
Market Cap 4.75B
Revenue (ttm) 4.47B
Net Income (ttm) 190.91M
Shares Out 86.75M
EPS (ttm) 2.20
PE Ratio 24.92
Forward PE n/a
Dividend 1.00 (1.82%)
Ex-Dividend Date n/a
Volume 855,946
Average Volume 223,341
Open 52.80
Previous Close 52.40
Day's Range 52.60 - 55.60
52-Week Range 39.40 - 58.00
Beta 0.43
RSI 74.00
Earnings Date Feb 27, 2025

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.